← back to search

Rohan Katipally

University of Illinois Chicago · US
Area of research
Otorhinolaryngology · Cancer Research
Research interest
Research interests include Head and Neck Cancer Studies, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, and Lung Cancer Diagnosis and Treatment.
h-index
10
citations
508
works
58
NIH funding
primary concept
Medicine
email

Recent publications

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer
JAMA Oncology 2025cited by 21position: middledoi
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas
Oral Oncology 2025cited by 9position: middledoi
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
Clinical Cancer Research 2025cited by 7position: middledoi
Abstract 2471: Interpretable HPV detection in head and neck cancer using foundation models and synthetic digital pathology
Cancer Research 2025cited by 0position: middledoi
Corrigendum to “Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas”. [Oral Oncol. 163 (2025) 107207]
Oral Oncology 2025cited by 0position: middledoi
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases
JAMA Oncology 2023cited by 31position: firstdoi
Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial–Mesenchymal Transition
Clinical Cancer Research 2023cited by 11position: firstdoi
RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy
Med 2023cited by 9position: middledoi
The oligometastatic spectrum in the era of improved detection and modern systemic therapy
Nature Reviews Clinical Oncology 2022cited by 83position: firstdoi
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma
International Journal of Radiation Oncology*Biology*Physics 2022cited by 79position: middledoi
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy
International Journal of Radiation Oncology*Biology*Physics 2022cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Aditya Juloori · University of Chicago8 papers (2022–2025)Sean P. Pitroda · University of Chicago Medical Center6 papers (2022–2023)Jeffrey Chin · University of California, San Francisco5 papers (2025–2025)Elizabeth A. Blair · Elgin Community College5 papers (2025–2025)Evgeny Izumchenko · University of Chicago5 papers (2025–2025)Alexander T. Pearson · RWTH Aachen University5 papers (2025–2025)Nishant Agrawal · Institute of Chartered Financial Analysts of India5 papers (2025–2025)Ari J. Rosenberg · University of Chicago5 papers (2025–2025)Everett E. Vokes · University of Illinois Chicago5 papers (2025–2025)Nicole A. Cipriani · University of Chicago4 papers (2025–2025)Ralph R. Weichselbaum · University of Chicago Medical Center4 papers (2022–2023)Mark W. Lingen · University of Chicago4 papers (2025–2025)Cindy Wang · University of Florida3 papers (2025–2025)Emma Dyer · University of Chicago3 papers (2025–2025) · 3 papers (2025–2025)Anna Trzcinska · University of Chicago3 papers (2025–2025)Hanna M. Hieromnimon · University of Chicago3 papers (2025–2025)James M. Dolezal · Geisinger Medical Center3 papers (2025–2025)Frederick M. Howard · University of Chicago3 papers (2025–2025)Sara Kochanny · University of Chicago3 papers (2025–2025)